India's Opto Circuits expands with Criticare
This article was originally published in Clinica
Bangalore-based Opto Circuits, said to be one of India's leading healthcare equipment manufacturers, is to grow its patient monitoring business with the acquisition of US firm Criticare Systems. Opto definitively agreed on Monday (Feb 25) to buy Milwaukee, Wisconsin-based Criticare for $5.50 per share, giving the total transaction a value of $68m. The purchase price represents a 19% premium over Criticare's closing price on Feb 22.
You may also be interested in...
Stephen Hahn’s low visibility period as the newly installed FDA commissioner comes to an abrupt end. Trump offers generous praise amid COVID-19 response – but how quickly might that change to blame?
The latest drug development news and highlights from the Pink Sheet US FDA Performance Tracker.
Assessment work also isn’t slowing down, the new and generic drug office directors said in an interview, but approval data offers a note of concern.